Press Release Hørsholm, Denmark (22 December 2020) – Allarity Therapeutics A/S (“Allarity” or the “Company”) today announced that it...
Press release ...
Study results are expected to support the Company's plans to file an IND application with the FDA for a Phase...
IRVINE, Calif.--(BUSINESS WIRE)--$NXGN #AmbulatoryHealthcare--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that President and...
RESTON, Va.--(BUSINESS WIRE)--Siemens Government Technologies (SGT), Inc. – the federally-focused U.S. arm of technology powerhouse Siemens – is honored to...
PARIS, FRANCE / ACCESSWIRE / December 21, 2020 / Abivax (Euronext Paris: FR0012333284 - ABVX), a clinical-stage biotechnology company harnessing...
The company and its CEO thank supporters and remain fully committed; company will also provide a series of GenViro! test...
The OrthoRegen® Center for Regenerative Orthopedics is taking action to protect patients and staff during the pandemic SANTA MONICA, CA...
Heru, Inc. comes out of stealth mode to announce the development of a novel artificial intelligence (AI) driven vision diagnostic...
Vancouver, British Columbia--(Newsfile Corp. - December 21, 2020) - Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) ("Sweet...
Anticipating an Exciting 2021 LAS VEGAS, NV / ACCESSWIRE / December 21, 2020 / Megola, Inc. (OTC PINK:MGON) (the "Company"),...
Supports Commercialization of TAEUSⓇ Product for Imaging NAFLD/NASH to December 2023 ANN ARBOR, MI / ACCESSWIRE / December 21, 2020...
Major market players are engaged in launching compact, ultra-modern devices with the purpose of targeting diverse end users. DUBAI, UAE...
Larazotide, a novel tight junction modulator, has shown positive effect in multiple lung models of acute respiratory distress, acute lung...
– Catalent has a proven track record of accelerating molecules from early development through commercial manufacturing – – Company targets...
DOYLESTOWN, Pa., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Neuropathix, Inc. (OTCQB: NPTX), (the “Company” or "Neuropathix"), a socially responsible pain...
Patient recruitment in Phase III trial has surpassed 60% Trial is expanded to Israel with first clinical site at Tel...
Transaction Expands Gainwell’s Capabilities as an Analytics-Driven Healthcare Technology Provider Cotiviti to Subsequently Acquire Certain Business Lines, Expanding Health Plan...
– exoIL-12 has demonstrated tissue-retained pharmacology, enhanced anti-tumor activity, potent M1 myeloid recruitment, and superior T cell responses in vivo...
Versamune® T-cell activating platform demonstrates breadth of anti-SARS-CoV-2 immune responses in a COVID-19 vaccine PDS Biotech Announces Mount Sinai Publication...